Latest Saturn V Capital Management LLC Stock Portfolio
$249Million
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Saturn V Capital Management LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Saturn V Capital Management LP reported an equity portfolio of $249.4 Millions as of 31 Mar, 2024.
The top stock holdings of Saturn V Capital Management LP are CRNX, ARGX, CYTK. The fund has invested 12.4% of it's portfolio in CRINETICS PHARMACEUTICALS IN and 10.4% of portfolio in ARGENX SE.
The fund managers got completely rid off CYMABAY THERAPEUTICS INC (CBAY), AMYLYX PHARMACEUTICALS INC (AMLX) and BIOGEN INC (BIIB) stocks. They significantly reduced their stock positions in MORPHIC HLDG INC (MORF), ITEOS THERAPEUTICS INC (ITOS) and APELLIS PHARMACEUTICALS INC (APLS). Saturn V Capital Management LP opened new stock positions in VAXCYTE INC (PCVX), ABIVAX SA and IRONWOOD PHARMACEUTICALS INC (IRWD). The fund showed a lot of confidence in some stocks as they added substantially to AMICUS THERAPEUTICS INC (FOLD), DISC MEDICINE INC and PHATHOM PHARMACEUTICALS INC (PHAT).
The top stock holdings of Saturn V Capital Management LP are CRNX, ARGX, CYTK. The fund has invested 12.4% of it's portfolio in CRINETICS PHARMACEUTICALS IN and 10.4% of portfolio in ARGENX SE.
The fund managers got completely rid off CYMABAY THERAPEUTICS INC (CBAY), AMYLYX PHARMACEUTICALS INC (AMLX) and BIOGEN INC (BIIB) stocks. They significantly reduced their stock positions in MORPHIC HLDG INC (MORF), ITEOS THERAPEUTICS INC (ITOS) and APELLIS PHARMACEUTICALS INC (APLS). Saturn V Capital Management LP opened new stock positions in VAXCYTE INC (PCVX), ABIVAX SA and IRONWOOD PHARMACEUTICALS INC (IRWD). The fund showed a lot of confidence in some stocks as they added substantially to AMICUS THERAPEUTICS INC (FOLD), DISC MEDICINE INC and PHATHOM PHARMACEUTICALS INC (PHAT).
New Buys
| Ticker | $ Bought |
|---|---|
| VAXCYTE INC | 12,649,300 |
| ABIVAX SA | 8,908,470 |
| IRONWOOD PHARMACEUTICALS INC | 8,230,180 |
| GERON CORP | 3,709,180 |
| CABALETTA BIO INC | 2,954,330 |
New stocks bought by Saturn V Capital Management LLC
Additions
| Ticker | % Inc. |
|---|---|
| AMICUS THERAPEUTICS INC | 349 |
| DISC MEDICINE INC | 293 |
| PHATHOM PHARMACEUTICALS INC | 212 |
| COGENT BIOSCIENCES INC | 110 |
| ARGENX SE | 28.18 |
Additions to existing portfolio by Saturn V Capital Management LLC
Reductions
| Ticker | % Reduced |
|---|---|
| MORPHIC HLDG INC | -59.67 |
| ITEOS THERAPEUTICS INC | -53.26 |
| APELLIS PHARMACEUTICALS INC | -50.00 |
| CYTOKINETICS INC | -41.16 |
| SYNDAX PHARMACEUTICALS INC | -23.28 |
| ASCENDIS PHARMA A/S | -21.5 |
| KALVISTA PHARMACEUTICALS INC | -20.23 |
| CRINETICS PHARMACEUTICALS IN | -16.13 |
Saturn V Capital Management LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| AMYLYX PHARMACEUTICALS INC | -16,181,200 |
| ASTRIA THERAPEUTICS INC | -7,608,290 |
| CYMABAY THERAPEUTICS INC | -17,720,900 |
| JASPER THERAPEUTICS INC | -1,093,720 |
| AMBRX BIOPHARMA INC | -751,601 |
| BIOGEN INC | -8,402,000 |
| ALNYLAM PHARMACEUTICALS INC | -1,976,690 |
Saturn V Capital Management LLC got rid off the above stocks
Current Stock Holdings of Saturn V Capital Management LLC
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| AMAM | AMBRX BIOPHARMA INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ANAB | ANAPTYSBIO INC | 5.29 | 586,031 | 13,197,400 | REDUCED | -11.78 | |
| APLS | APELLIS PHARMACEUTICALS INC | 1.68 | 71,463 | 4,200,600 | REDUCED | -50.00 | |
| ARGX | ARGENX SE | 10.36 | 65,597 | 25,826,900 | ADDED | 28.18 | |
| ASND | ASCENDIS PHARMA A/S | 6.27 | 103,428 | 15,635,200 | REDUCED | -21.5 | |
| ATXS | ASTRIA THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| BIIB | BIOGEN INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 4.17 | 119,188 | 10,409,900 | UNCHANGED | 0.00 | |
| CABA | CABALETTA BIO INC | 1.18 | 173,173 | 2,954,330 | NEW | ||
| CBAY | CYMABAY THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| COGT | COGENT BIOSCIENCES INC | 4.30 | 1,595,020 | 10,718,500 | ADDED | 110 | |
| CRNX | CRINETICS PHARMACEUTICALS IN | 12.39 | 660,143 | 30,901,300 | REDUCED | -16.13 | |
| CYTK | CYTOKINETICS INC | 7.41 | 263,701 | 18,488,100 | REDUCED | -41.16 | |
| FOLD | AMICUS THERAPEUTICS INC | 4.24 | 898,381 | 10,582,900 | ADDED | 349 | |
| GERN | GERON CORP | 1.49 | 1,124,000 | 3,709,180 | NEW | ||
| IRWD | IRONWOOD PHARMACEUTICALS INC | 3.30 | 944,912 | 8,230,180 | NEW | ||
| ITOS | ITEOS THERAPEUTICS INC | 2.12 | 387,095 | 5,279,980 | REDUCED | -53.26 | |
| JSPR | JASPER THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| KALV | KALVISTA PHARMACEUTICALS INC | 6.86 | 1,441,950 | 17,101,600 | REDUCED | -20.23 | |
| MORF | MORPHIC HLDG INC | 1.21 | 85,632 | 3,014,250 | REDUCED | -59.67 | |
| MRUS | MERUS N V | 6.80 | 376,629 | 16,959,600 | REDUCED | -3.26 | |
| PCVX | VAXCYTE INC | 5.07 | 185,175 | 12,649,300 | NEW | ||
| PHAT | PHATHOM PHARMACEUTICALS INC | 2.13 | 500,987 | 5,320,480 | ADDED | 212 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 3.80 | 397,997 | 9,472,330 | REDUCED | -23.28 | |
| DISC MEDICINE INC | 6.36 | 254,803 | 15,864,000 | ADDED | 293 | ||
| ABIVAX SA | 3.57 | 622,970 | 8,908,470 | NEW |